Anke Hantson

Development of Resistance against Diketo Derivatives of Human Immunodeficiency Virus Type 1 by Progressive Accumulation of Integrase Mutations

Valery Fikkert, Bénédicte Van Maele, Jo Vercammen et al. · Journal of Virology · 2003 · 98 citations · Full text

Resistance of Human Immunodeficiency Virus Type 1 to the High-Mannose Binding Agents Cyanovirin N and Concanavalin A

Myriam Witvrouw, Valery Fikkert, Anke Hantson et al. · Journal of Virology · 2005 · 95 citations · Full text

Immunology, Glycobiology, Hm Glycans +19

<i>env</i> Chimeric Virus Technology for Evaluating Human Immunodeficiency Virus Susceptibility to Entry Inhibitors

Valery Fikkert, Peter Cherepanov, Kristel Van Laethem et al. · Antimicrobial Agents and Chemotherapy · 2002 · 37 citations · Full text

Potent and Selective Inhibition of HIV and SIV by Prostratin Interacting with Viral Entry

Myriam Witvrouw, Christophe Pannecouque, Valery Fikkert et al. · Antiviral chemistry & chemotherapy · 2003 · 19 citations

Immunology, Pharmacotherapy, Antiviral Drug +17

Selection of human immunodeficiency virus type 1 resistance against the pyranodipyrimidine V-165 points to a multimodal mechanism of action

Anneleen Hombrouck, Anke Hantson, Barbara Van Remoortel et al. · Journal of Antimicrobial Chemotherapy · 2007 · 18 citations · Full text